At Home with Hostility

By Thomas Ruby and Denise M. Monack At Home with Hostility How do pathogenic bacteria evade mammalian immune surveillance to establish persistent infection? Tuberculosis infection Scott Camazine / Photo Researchers, Inc. Long-term bacterial infections pose several fundamental biological questions: How metabolically active are bacteria during a persistent infection? Are they dividing, or in a state of quiescence? And how do these bacteria evade the immune system

| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Long-term bacterial infections pose several fundamental biological questions: How metabolically active are bacteria during a persistent infection? Are they dividing, or in a state of quiescence? And how do these bacteria evade the immune system for so long?

Acute infections by pathogenic bacteria cause a dramatic activation of the innate and adaptive immune responses. If the pathogen survives initial contact with the host’s innate immune system (and the host is not killed), the infection is usually cleared by the host’s adaptive immune system. However, some bacterial pathogens maintain infections for the lifetime of their mammalian hosts, even in the presence of a robust immune response.

Most of what we’ve learned about persistent infections comes from the study of several well-known illnesses. For example, Helicobacter pylori, the cause of most stomach ulcers, inhabits the stomach lining, where its persistence can be lifelong; Mycobacterium tuberculosis is able to establish long-term infections that ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Thomas Ruby

    This person does not yet have a bio.
  • Denise M. Monack

    This person does not yet have a bio.

Published In

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide